ATG-31697-39510
3 vaccinations
7 coded responses
24 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 730 / OK
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 2 — Pfizer-BioNTech
-
2021-02-26
Survey response — day 0, dose 2MedDRA: Dizziness, Heart rate increased — Feeling: Fair · Site: Pain · Headache, NauseaFree text: Dizziness and increased heart rateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Increased heart rateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-05
- 2021-03-14
- 2021-03-19
- 2021-03-26
- 2021-04-09
-
2021-08-27
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-04
Dose 3 — Pfizer-BioNTech
-
2021-12-04
Survey response — day 0, dose 3MedDRA: Dizziness — Feeling: Fair · Site: PainFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory tract congestion — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-07
- 2021-12-09
- 2021-12-11
- 2021-12-20
- 2021-12-27
- 2022-01-10
- 2022-01-15
-
2022-03-07
Survey response — 3 months, dose 3MedDRA: Pharyngitis streptococcal — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Strep throatMedDRA releases: 2024-11 · check-in free text available
- 2022-06-06
-
2022-12-04
Survey response — 12 months, dose 3MedDRA: Arthritis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: ArthritisMedDRA releases: 2024-11 · check-in free text available
-
2022-12-04
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-02-26 | Pfizer-BioNTech | |
| 3 | 2021-12-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): Dizziness and increased heart rate
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Increased heart rate
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 10 — day 0, dose 3
Systemic reaction (other): Dizziness
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Congestion
Release 11 — 3 months, dose 3
Symptoms: Strep throat
Release 12 — 12 months, dose 3
Symptoms: Arthritis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthritis | · | · | ✓ |
| SD | Pharyngitis streptococcal | · | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release